BIOLUMI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BIOLUMI Trademark

Serial Number: 79177788 • Registration: 5047458

BIOLUMI is a trademark filed by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. on July 8, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. (27 trademarks)

21st Floor, Snibe Building,

Entity Type: 99

Trademark Details

Filing Date

July 8, 2015

Registration Date

September 27, 2016

Published for Opposition

July 12, 2016

Goods & Services

[ Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; chemical preparations for the diagnosis of pregnancy; Medicated serums for invitro diagnosis of pregnancy and treatment of blood conditions during pregnancy; Serotherapeutic medicines for the treatment of hepatitis; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes ]

Blood testing apparatus; massage apparatus; Testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; Apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples;Diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; Ultrasonic devices for medical use, namely, clinical ultrasonic diagnostic apparatus; artificial limbs; Multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2026 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 27, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Jul 10, 2025 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 18, 2023 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Mar 13, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 13, 2023 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 19, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 19, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 19, 2022 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 10, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Apr 30, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2022 APRE
TEAS SECTION 71 RECEIVED
Sep 27, 2021 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 20, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 23, 2017 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 29, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 29, 2016 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 15, 2016 OPNX
PUBLISHED FOR OPPOSITION
Jul 12, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 22, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 22, 2016 OP2R
NOTICE OF PUBLICATION
Jun 22, 2016 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 9, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2016 TROA
NON-FINAL ACTION MAILED
Jan 27, 2016 CNRT
NON-FINAL ACTION WRITTEN
Jan 27, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2016 CRFA
ASSIGNED TO LIE
Jan 22, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2016 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2016 TROA
REFUSAL PROCESSED BY IB
Jan 5, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2015 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 15, 2015 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 15, 2015 MAFR
NON-FINAL ACTION WRITTEN
Dec 14, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 10, 2015 REPR